Abbott Laboratories (ABT.SW) saw a sharp 12.00% drop in pre-market trading on SIX, reaching CHF88.00, driven by profit-taking and market re-pricing following recent headlines. The stock is now well below its 50-day average, with immediate support identified around CHF85.00. Despite the technical oversold conditions and premium valuation, Meyka AI issues a “BUY” suggestion and projects a one-year price target of CHF100.56, while cautioning traders to consider short-term risks and conservative strategies.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Pre-market: ABT.SW Abbott Laboratories (SIX) -12.00% to CHF88.00: watch CHF85.00
Abbott Laboratories (ABT.SW) saw a sharp 12.00% drop in pre-market trading on SIX, reaching CHF88.00, driven by profit-taking and market re-pricing following recent headlines. The stock is now well below its 50-day average, with immediate support identified around CHF85.00. Despite the technical oversold conditions and premium valuation, Meyka AI issues a “BUY” suggestion and projects a one-year price target of CHF100.56, while cautioning traders to consider short-term risks and conservative strategies.